This product is intended for in vitro diagnostic for the quantitative calibration of automated, semi-automated, or manual clinical chemistry systems for the measurement of ammonia, ethanol and lactate. Each lot of DOCUMENT Ammonia, Ethanol, Lactate Calibrator has lot specific calibration set point values for the various analytical systems on which is was assayed. This material is not intended for use on those clinical chemistry systems employing reflectance spectroscopy.
Device Story
The DOCUMENT Ammonia/Ethanol/Lactate Calibrator is an in vitro diagnostic product used to calibrate clinical chemistry analyzers. It provides lot-specific calibration set point values for ammonia, ethanol, and lactate measurements. The calibrator is used in clinical laboratory settings by laboratory professionals to ensure the accuracy of analytical systems. It is not compatible with systems using reflectance spectroscopy. By providing known reference values, the device enables the clinical chemistry system to accurately quantify patient samples, supporting clinical decision-making related to ammonia, ethanol, and lactate levels.
Clinical Evidence
Bench testing only.
Technological Characteristics
In vitro diagnostic calibrator material; liquid or lyophilized form (implied); designed for use with automated, semi-automated, or manual clinical chemistry systems; excludes reflectance spectroscopy-based systems.
Indications for Use
Indicated for in vitro diagnostic quantitative calibration of clinical chemistry systems measuring ammonia, ethanol, and lactate. Not for use on systems employing reflectance spectroscopy.
Regulatory Classification
Identification
A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)
Special Controls
*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
K031880 — AMMONIA/ETHANOL/CO2 CALIBRATOR, CONTROL NORMAL, CONTROL ABNORMAL · Roche Diagnostics Corp. · Jul 16, 2003
K042406 — OLYMPUS LACTATE, OSR6193 · Olympus America, Inc. · Dec 3, 2004
K973054 — ETHYL ALCOHOL CLINICAL STANDARD SOLUTIONS · Emd Chemicals, Inc. · Oct 1, 1997
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized emblem featuring three curved shapes that resemble a bird in flight or a stylized human figure. The logo is printed in black and white.
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
APR 2 4 1998 Ms. Christine V. Beach Manager, Regulatory Affairs CASCO Standards 500 Riverside Industrial Parkway Portland, Maine 04103-1418
Re : K981436 Trade Name: DOCUMENT Ammonia/Ethanol/Lactate Calibrator for use on BMC Hitachi 717 Analyzer Requlatory Class: II Product Code: JIX Dated: April 9, 1998 Received: April 14,1998
Dear Ms. Beach:
laws or regulations.
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to leqally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the qeneral controls provisions of the Act. The general controls provisions of the Act include requirements for annual reqistration, listing of devices, good manufacturing practice, labeling, and prohibitions aqainst misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Reqister. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal
{1}------------------------------------------------
## Page 2
Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88), this device may require a CLIA complexity categorization. To determine if it does, you should contact the Centers for Disease Control and Prevention (CDC) at (770)488-7655.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Steven Putman
Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health
{2}------------------------------------------------
510(k) Number : K981436
DOCUMENI" Ammonia, Ethanol, Lactate Calibrator Device Name:
Indications for Use:
This product is intended for in vitro diagnostic for the quantitative calibration of automated, semi-automated, or manual clinical chemistry systems for the measurement of ammonia, ethanol and lactate. Each lot of DOCUMENT" Ammonia, Ethanol, Lactate Calibrator has lot specific calibration set point values for the various analytical systems on which is was assayed. This material is not intended for use on those clinical chemistry systems employing reflectance spectroscopy.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
ાર
Over-the -Counter Use
(Optional Format 1-2-96)
Cluss Alrz
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.